latest news releases from the newsroom
ViroPharma Incorporated to Acquire U.S. Vancocin Brand from Lilly
EXTON, Pa., Oct. 18, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM), a pharmaceutical company focused on developing and commercializing products that address serious diseases treated by physician specialists in areas including hospital settings, transplant medicine and gastroenterology, today announced that it has entered into an agreement to acquire all rights in the U.S. to manufacture, market and sell Vancocin(R) Pulvules(R), the oral capsule formulation of Vancocin (vancomycin hydrochloride), as well as rights to certain related Vancocin products, from Eli Lilly and Company (Lilly) (NYSE:LLY). Oral Vancocin is a potent antibiotic approved by the U.S. Food and Drug Administration to treat enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains) and antibiotic-associated pseudomembranous colitis caused by Clostridium difficile.
Federal Home Loan Bank of Des Moines
Federal Home Loan Bank of Des Moines Hosts Fall Conference in St. Louis
MEDIA ADVISORY, Oct. 18, 2004 (PRIMEZONE) -- The Federal Home Loan Bank of Des Moines has an impressive line-up of nationally-known speakers scheduled for its 2004 Annual Fall Conference, Meet Me in St. Louis. More than 300 members from the Bank's five-state district of Iowa, Minnesota, Missouri, North Dakota and South Dakota are expected to attend the event which begins today. The Conference, designed to provide Bank customers with three days of education, offers an excellent overview of current trends and issues in the banking industry and beyond. Participants will learn about topics that are relevant to their business needs and important in today's changing financial environment.
Molecular Diagnostics, Inc.
Molecular Diagnostics, Inc. and MonoGen, Inc. Reach Settlement on AccuMed Technology
CHICAGO, Oct. 18, 2004 (PRIMEZONE) -- Molecular Diagnostics, Inc. (OTCBB:MCDG) ("MDI") and its wholly owned subsidiary, AccuMed International, Inc. ("AccuMed") collectively ("MOI" Group), based in Chicago, Illinois, and Monogen, Inc. ("MonoGen"), based in Vernon Hills, Illinois, jointly announce the settlement of their dispute arising from the "AccuMed/MonoGen License" by which AccuMed, in December 2000 granted to MonoGen a license to specific AccuMed related technologies that may be used, in part, for early cancer detection, diagnosis and monitoring. As part of the settlement, AccuMed assigned to MonoGen all of the AccuMed patents, patent applications, trade secrets, trademarks, copyrights and know-how covering the subject AccuMed patents and technology, as well as all applicable AccuMed equipment and spare parts.
Ontus Telcommunications Corp.
Ontus Telecommunications Corp Teams With Level 3 for Voice Over IP Phone Service
PORTLAND, Ore., Oct. 18, 2004 (PRIMEZONE) -- Ontus Telecommunications Corp. (Pink Sheets:ONTT), an FCC licensed international and long distance communications carrier, today announced it has signed an agreement that makes Level 3 Communications, Inc. (Nasdaq:LVLT) the underlying Voice over IP (VoIP) provider for its VoIP phone service. Under the new contract, Ontus will use Level 3's (3)VoIP Enhanced (SM) Local service to round out its suite of voice over the internet telecom service offerings.
Brower Piven, A Professional Corporation
Law Offices Of Charles J. Piven, P.A. Announces Class Action Lawsuit Against AXT, Inc. -- AXTI
BALTIMORE, Oct. 18, 2004 (PRIMEZONE) -- Law Offices Of Charles J. Piven, P.A. today announced that a securities class action was commenced on behalf of shareholders who purchased, converted, exchanged or otherwise acquired the common stock of AXT, Inc. (Nasdaq:AXTI) between February 6, 2001 and April 27, 2004, inclusive (the "Class Period").
Mobular Technologies, Inc.
Mobular Technologies, Inc. Appoints Allen Dillard Chief Executive Officer
HUNTSVILLE, Ala., Oct. 18, 2004 (PRIMEZONE) -- Mobular Technologies(r), Inc. ("Mobular" or the "Company") announced today that Allen Dillard has been appointed as the Company's Chief Executive Officer, effective immediately. Dillard currently serves as the Company's Chief Operating Officer and as a member of its Board of Directors. Dillard succeeds Stuart Obermann, who has announced a reduction in his day-to-day involvement due to a family medical situation.
Honor Your Father Campaign for Prostate Cancer Research
Honor Your Father Campaign Hits Million Dollar Mark
HOUSTON, Oct. 18, 2004 (PRIMEZONE) -- Since its September 9 launch at Houston City Hall, the Honor Your Father Campaign for Prostate Cancer Research has raised more than $1 million, including a dollar-for-dollar matching gift from The Lester and Sue Smith Foundation. The Honor Your Father Campaign is a series of fundraising and awareness events through Father's Day 2005, directly funding critical prostate cancer research projects at Baylor College of Medicine's Scott Department of Urology. The impressive early success of the Honor Your Father Campaign is made possible through the generous support of members of The Partnership for Baylor College of Medicine, along with other individual donors, corporations, and foundations and the Smith's challenge match.
Oakley to Webcast Conference Call Discussing Third-Quarter Financial Results
FOOTHILL RANCH, Calif., Oct. 18, 2004 (PRIMEZONE) -- Oakley, Inc. (NYSE:OO) today said it expects to announce on Thursday, October 21, 2004, its financial results for the third quarter ended September 30, 2004. The company plans to issue a news release that day at approximately 4:00 p.m. Eastern Time, immediately following the closing of regular stock market trading hours. Following the news release, Oakley management will host a conference call beginning at 4:30 p.m. Eastern Time to review the results.